metricas
covid
Annals of Hepatology LIVER FIBROSIS IN INDIVIDUALS WITH METABOLIC DYSFUNCTION–ASSOCIATED STEATOTIC ...
Journal Information
Vol. 30. Issue S2.
Abstracts of the 2025 Annual Meeting of the ALEH
(September 2025)
Vol. 30. Issue S2.
Abstracts of the 2025 Annual Meeting of the ALEH
(September 2025)
#117
Full text access
LIVER FIBROSIS IN INDIVIDUALS WITH METABOLIC DYSFUNCTION–ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) IN LATIN AMERICA: INTERIM RESULTS FROM THE STELLA STUDY
Visits
192
Luis Antonio Díaz Piga1, Francisco Idalsoaga2, Mario G. Pessoa3, Claudia Pinto Marques Souza de Oliveira3, Patricia Zitelli3, Ezequiel Ridruejo4, Mirta Peralta5, Cesar Castro6, Jorge Garavito-Rentería6, Gustavo Ayares2, Nancy Solis2, María Paz Orellana2, Sebastián Marciano7, Adrian Gadano7, Jorge Martínez Morales7, María José Acosta7, Martin Tagle8, Hugo Cedron8, Ismael Yepes Barreto9, Dalis Pérez9..., Estefania Liza10, Javier Díaz Ferrer10, Daniela Simian11, Juan Pablo Roblero12, Pamela Gil12, Scherezada Mejía Loza13, Veeral Ajmera1, Arun J. Sanyal14, Rohit Loomba1, Juan Pablo Arab14, Marco Arrese2Ver más
1 MASLD Research Center. Division of Gastroenterology and Hepatology. University of California San Diego, USA.
2 Departamento de Gastroenterología. Escuela de Medicina. Pontificia Universidad Católica de Chile.
3 Departamento de Gastroenterologia. Universidade de São Paulo, Brasil.
4 Hepatology Section. Department of Medicine. Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno “CEMIC”, Argentina.
5 Hospital Francisco J. Muñiz, Argentina.
6 Hospital Nacional Arzobispo Loayza, Peru.
7 Departamento de Gastroenterología. Hospital Italiano de Buenos Aires, Argentina.
8 Clinica Anglo Americana, Peru.
9 Universidad de Cartagena, Colombia.
10 Universidad Nacional Mayor de San Marcos, Perú.
11 Sección Gastroenterología, Chile.
12 Hospital Clínico Universidad de Chile. Escuela de Medicina. Universidad de Chile.
13 Hospital Juárez de México.
14 Division of Gastroenterology. Hepatology. and Nutrition. Department of Internal Medicine. Virginia Commonwealth University School of Medicine, USA.
Ver más
This item has received
Article information
Abstract
Full Text
Download PDF
Statistics
Figures (1)
Special issue
This article is part of special issue:
Vol. 30. Issue S2

Abstracts of the 2025 Annual Meeting of the ALEH

More info
Introduction and Objectives

Prospective data on liver-fibrosis risk among Latin Americans with MASLD remain scarce, although genetic susceptibility and lifestyle behaviors may heighten vulnerability. This multinational, prospective study aims to define the principal determinants of fibrosis in this high-risk population across Latin America.

Materials and Methods

We performed a cross-sectional baseline analysis of the STELLA study, which is prospectively enrolling adults with MASLD (2023 criteria) at 10 centers (Argentina 15.1%, Brazil 66.2%, Chile 5.9%, Colombia 1.9%, Mexico 0.3%, Peru 10.6%). Alcohol intake, dietary patterns, and vibration-controlled transient elastography (VCTE) were assessed in all participants. When biopsy was unavailable, fibrosis was staged by liver stiffness measurements (LSMs) on VCTE cut-offs (advanced ≥ 8.8 kPa, cirrhosis ≥ 11.8 kPa). Factors associated with liver stiffness were examined with multivariable linear regression adjusted for age, sex, body mass index (BMI), type 2 diabetes mellitus (T2DM), hypertension, and dyslipidemia.

Results

A total of 370 participants were analyzed (median age 66 [58–73] years; 66.7% women; median BMI 30.9 [27.5–34.8] kg/m2). The prevalence of T2DM was 55.8%, hypertension 38.3%, and dyslipidemia 39.4%. The median alcohol intake was 0 [0–28] grams/week. Median liver stiffness was 9.2 [6.1–16.6] kPa, with advanced fibrosis present in 53.2% and cirrhosis in 18.8%. In the adjusted model, female sex (β = +3.0 kPa; 95%CI 0.2–5.8; p=0.034), T2DM (β = +4.9 kPa; 95%CI 2.2–7.6; p<0.001), and dyslipidemia (β = +3.9 kPa; 95%CI 1.2–6.5; p=0.005) were independently associated with higher LSM values, with T2DM showing the strongest effect (Figure).

Conclusions

In this well-characterized cohort of Latin-American adults with MASLD, female sex, T2DM, and dyslipidemia emerged as leading risk factors for liver fibrosis. The STELLA project, including a larger sample and longitudinal follow-up, may further clarify the natural history of MASLD in Latin America (FONDECYT 1241450).

Full Text

Conflict of interest: None

Figure. Adjusted association between age and liver stiffness measurement by vibration-controlled transient elastography (VCTE), according to the presence or absence of type 2 diabetes mellitus (T2DM). Model was adjusted for sex, body mass index, hypertension, and dyslipidemia. Higher stiffness values indicate greater hepatic fibrosis.

Download PDF
Article options
Tools